You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for New Drug Application (NDA): 012342


✉ Email this page to a colleague

« Back to Dashboard


NDA 012342 describes PARNATE, which is a drug marketed by Concordia and is included in one NDA. It is available from two suppliers. Additional details are available on the PARNATE profile page.

The generic ingredient in PARNATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
Summary for 012342
Tradename:PARNATE
Applicant:Concordia
Ingredient:tranylcypromine sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 012342
Mechanism of ActionMonoamine Oxidase Inhibitors
Medical Subject Heading (MeSH) Categories for 012342
Suppliers and Packaging for NDA: 012342
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PARNATE tranylcypromine sulfate TABLET;ORAL 012342 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-5590 0591-5590-01 100 TABLET, FILM COATED in 1 BOTTLE (0591-5590-01)
PARNATE tranylcypromine sulfate TABLET;ORAL 012342 NDA Concordia Pharmaceuticals Inc. 59212-447 59212-447-10 100 TABLET, FILM COATED in 1 BOTTLE (59212-447-10)

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Aug 16, 1985TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.